Independent directors’ comments on the 13th meeting of the first board of directors of the company
Prior approval opinions on relevant matters
In accordance with the company law of the people’s Republic of China, the rules for independent directors of listed companies (announcement [2022] No. 14 of China Securities Regulatory Commission), the Listing Rules of GEM stocks on Shenzhen Stock Exchange (revised in December 2020), and the self regulatory guidelines for listed companies on Shenzhen Stock exchange No. 2 – standardized operation of GEM listed companies (revised in 2022) (SZS [2022] No. 14) and the Sino Biological Inc(301047) articles of Association (hereinafter referred to as the “articles of association”) and other relevant provisions. As independent directors of Sino Biological Inc(301047) (hereinafter referred to as the “company”), we, based on the principle of prudence and objectivity and the position of independent judgment, reviewed the relevant proposals considered at the 13th meeting of the first board of directors After knowing the relevant information, make the following prior approval:
1、 Prior approval opinions on the proposal on the implementation of daily connected transactions in 2021 and the prediction of daily connected transactions in 2022
According to the review, the daily connected transactions of the company in 2021 and 2022 are expected to be required by the company’s normal production and operation activities. The transaction pricing is reasonable and fair, and the principles of equality, voluntariness, equivalence and compensation are strictly followed. There is no situation that damages the interests of the company and other shareholders, especially small and medium-sized shareholders, and will not affect the independence of the company, Nor will it affect the company’s ability to continue as a going concern.
In view of the above reasons, we unanimously recognize the actual implementation of the company’s daily related party transactions in 2021, agree to implement the forecast of daily related party transactions in 2022, and agree to submit the proposal to the 13th meeting of the first board of directors for deliberation.
2、 Prior approval opinions on the proposal on renewing the appointment of audit institutions in 2022
After verification, Zhitong Certified Public Accountants (special general partnership) meets the relevant requirements of the securities law, has the experience and ability to provide audit services for listed companies, can meet the requirements of the company’s audit work in 2022, takes into account the company’s business development and the needs of the overall audit, and maintains the consistency and continuity of the audit work, We agree to renew the appointment of Zhitong Certified Public Accountants (special general partnership) as the company’s audit institution in 2022, and agree to submit the proposal to the 13th meeting of the first board of directors for deliberation. independent director:
Yu Changyuan, Yin Shizhou, pan Weijiang
Time: February 25, 2022
